Dec '21
Emerald Health Therapeutics Reports 2021 AGM Results
Vancouver, British Columbia--(Newsfile Corp. - December 31, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has announced the results of voting at its annual general meeting held December 30, 2021. Shareholders voted in favour of all resolutions, setting the...
Nov '21
Emerald Health Therapeutics Pivots Out of Recreational and Medical Cannabis and into Pharmaceutical Development
Vancouver, British Columbia--(Newsfile Corp. - November 29, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald" or the "Company") today announced that it is exiting the recreational and medical cannabis business and pivoting to a pharmaceutical development focus....
Nov '21
Emerald Health Therapeutics and HYTN Cannabis to Launch Cannabis Beverages in Canada
Emerald partners with HYTN to sell and distribute HYTN's calorie-free, fast-acting THC-infused sparkling cannabis beverages as new alternative in the rapidly growing cannabis beverage market
Vancouver, British Columbia--(Newsfile Corp. - November 3, 2021) - Emerald Health Therapeutics, Inc. (CSE:...
Oct '21
Emerald Health Therapeutics Strategic Licensee, FlowerPod, Unveils Groundbreaking Dose-Controlled Cannabis Vaping Product, New Brand, and U.S. Launch Plans
Emerald Patent Licensee Announces Partnership with Leading Cannabis Vaporization Technology Company, Grenco Science
Vancouver, British Columbia--(Newsfile Corp. - October 28, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") announces that its partner, FlowerPod LLC,...
Sep '21
Emerald Health Therapeutics Announces Chief Financial Officer Transition
Vancouver, British Columbia--(Newsfile Corp. - September 10, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") announced today that its Chief Financial Officer, Jenn Hepburn, will be stepping down from her position at Emerald, effective October 15, 2021, to pursue...